An ADAM10 promoter polymorphism is a functional variant in severe sepsis patients and confers susceptibility to the development of sepsis
详细信息 查看全文
- 作者：Lili Cui (1)
Yan Gao (2)
Yuliu Xie (3)
Yan Wang (4)
Yujie Cai (1)
Xin Shao (3)
Xiaotang Ma (1)
You LI (1)
Guoda Ma (1)
Gen Liu (1)
Wanwen Cheng (1)
Yu Liu (1)
Tingting Liu (1)
Qunwen Pan (1)
Hua Tao (1)
Zhou Liu (1)
Bin Zhao (1)
Yiming Shao (3)
Keshen Li (1)
1. Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases ; Affiliated Hospital of Guangdong Medical College ; Renmin street south 57 ; Xiashan district ; Zhanjiang City ; 524001 ; Guangdong Province ; PR China
2. The Intensive Care Unit ; the Forth Affiliated Hospital of Harbin Medical University ; Harbin ; China
3. The Intensive Care Unit ; Affiliated Hospital of Guangdong Medical College ; Zhanjiang ; PR China
4. Clinical Research Center of Guangdong Medical College ; Affiliated Hospital of Guangdong Medical College ; Zhanjiang ; PR China - 刊名：Critical Care
- 出版年：2015
- 出版时间：December 2015
- 年：2015
- 卷：19
- 期：1
- 全文大小：911 KB
- 参考文献：1. Kauss, IA, Grion, CM, Cardoso, LT, Anami, EH, Nunes, LB, Ferreira, GL (2010) The epidemiology of sepsis in a Brazilian teaching hospital. Braz J Infect Dis. 14: pp. 264-270 CrossRef
2. McPherson, D, Griffiths, C, Williams, M, Baker, A, Klodawski, E, Jacobson, B (2013) Sepsis-associated mortality in England: an analysis of multiple cause of death data from 2001 to 2010. BMJ Open. 3: pp. e002586 CrossRef
3. Moore, LJ, McKinley, BA, Turner, KL, Todd, SR, Sucher, JF, Valdivia, A (2011) The epidemiology of sepsis in general surgery patients. J Trauma. 70: pp. 672-680 CrossRef
4. Baghel, K, Srivastava, RN, Chandra, A, Goel, SK, Agrawal, J, Kazmi, HR (2014) TNF-alpha, IL-6, and IL-8 cytokines and their association with TNF-alpha-308聽G/A polymorphism and postoperative sepsis. J Gastrointest Surg. 18: pp. 1486-1494 CrossRef
5. Barratt-Due, A, Thorgersen, EB, Lindstad, JK, Pharo, A, Brekke, OL, Christiansen, D (2010) Selective inhibition of TNF-alpha or IL-1 beta does not affect E. coli-induced inflammation in human whole blood. Mol Immunol 47: pp. 1774-1782 CrossRef
6. Thompson, CM, Holden, TD, Rona, G, Laxmanan, B, Black, RA, O鈥橩eefe, GE (2014) Toll-like receptor 1 polymorphisms and associated outcomes in sepsis after traumatic injury: a candidate gene association study. Ann Surg. 259: pp. 179-185 CrossRef
7. Ozkan, H, Koksal, N, Cetinkaya, M, Kilic, S, Celebi, S, Oral, B (2012) Serum mannose-binding lectin (MBL) gene polymorphism and low MBL levels are associated with neonatal sepsis and pneumonia. J Perinatol. 32: pp. 210-217 CrossRef
8. Behnes, M, Bertsch, T, Hoffmann, U (2013) TIMP-1 gene polymorphism: are genetics able to predict outcome of septic patients?. Crit Care. 17: pp. 170 CrossRef
9. Giacconi, R, Costarelli, L, Malavolta, M, Piacenza, F, Galeazzi, R, Gasparini, N (2014) Association among 1267 A/G HSP70-2, 鈭?08聽G/A TNF-alpha polymorphisms and pro-inflammatory plasma mediators in old ZincAge population. Biogerontology. 15: pp. 65-79 CrossRef
10. Edwards, DR, Handsley, MM, Pennington, CJ (2008) The ADAM metalloproteinases. Mol Aspects Med. 29: pp. 258-289 CrossRef
11. Chaimowitz, NS, Kang, DJ, Dean, LM, Conrad, DH (2012) ADAM10 regulates transcription factor expression required for plasma cell function. PLoS One. 7: pp. e42694 CrossRef
12. Dreymueller, D, Pruessmeyer, J, Groth, E, Ludwig, A (2012) The role of ADAM-mediated shedding in vascular biology. Eur J Cell Biol. 91: pp. 472-485 CrossRef
13. Vorst, EP, Keijbeck, AA, Winther, MP, Donners, MM (2012) A disintegrin and metalloproteases: molecular scissors in angiogenesis, inflammation and atherosclerosis. Atherosclerosis. 224: pp. 302-308 CrossRef
14. Crawford, HC, Dempsey, PJ, Brown, G, Adam, L, Moss, ML (2009) ADAM10 as a therapeutic target for cancer and inflammation. Curr Pharm Des. 15: pp. 2288-2299 CrossRef
15. Hundhausen, C, Misztela, D, Berkhout, TA, Broadway, N, Saftig, P, Reiss, K (2003) The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood. 102: pp. 1186-1195 CrossRef
16. Hikita, A, Tanaka, N, Yamane, S, Ikeda, Y, Furukawa, H, Tohma, S (2009) Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-alpha. Biochem Cell Biol. 87: pp. 581-593 CrossRef
17. Chalaris, A, Garbers, C, Rabe, B, Rose-John, S, Scheller, J (2011) The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. Eur J Cell Biol. 90: pp. 484-494 CrossRef
18. Yamamoto, J, Maeno, K, Takada, T, Kakutani, K, Yurube, T, Zhang, Z (2013) Fas ligand plays an important role for the production of pro-inflammatory cytokines in intervertebral disc nucleus pulposus cells. J Orthop Res. 31: pp. 608-615 CrossRef
19. Hashizume, M, Higuchi, Y, Uchiyama, Y, Mihara, M (2011) IL-6 plays an essential role in neutrophilia under inflammation. Cytokine. 54: pp. 92-99 CrossRef
20. Nygaard, TK, Pallister, KB, Zurek, OW, Voyich, JM (2013) The impact of alpha-toxin on host cell plasma membrane permeability and cytokine expression during human blood infection by CA-MRSA USA300. J Leukoc Biol. 94: pp. 971-979 CrossRef
21. Zhu, LB, Zhao, ST, Xu, TZ, Wang, H (2014) Tumor necrosis factor-alpha-induced a disintegrin and metalloprotease 10 increases apoptosis resistance in prostate cancer cells. Oncol Lett. 7: pp. 897-901
22. Powers, ME, Kim, HK, Wang, Y, Bubeck, WJ (2012) ADAM10 mediates vascular injury induced by Staphylococcus aureus alpha-hemolysin. J Infect Dis. 206: pp. 352-356 CrossRef
23. Mathews, JA, Ford, J, Norton, S, Kang, D, Dellinger, A, Gibb, DR (2011) A potential new target for asthma therapy: a disintegrin and metalloprotease 10 (ADAM10) involvement in murine experimental asthma. Allergy. 66: pp. 1193-1200 CrossRef
24. Prinzen, C, Muller, U, Endres, K, Fahrenholz, F, Postina, R (2005) Genomic structure and functional characterization of the human ADAM10 promoter. Faseb J. 19: pp. 1522-1524
25. Song, JH, Yu, JT, Liu, M, Yan, CZ, Tan, L (2011) Genetic association between ADAM10 gene polymorphism and Alzheimer鈥檚 disease in a Northern Han Chinese population. Brain Res. 1421: pp. 78-81 CrossRef
26. Bekris, LM, Galloway, NM, Millard, S, Lockhart, D, Li, G, Galasko, DR (2011) Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer鈥檚 disease. Neurobiol Aging. 32: pp. 513-556 CrossRef
27. Plamont, MA, Chasseigneaux, S, Delasnerie-Laupretre, N, Beaudry, P, Peoc鈥橦, K, Laplanche, JL (2003) Variation at the ADAM10 gene locus is not associated with Creutzfeldt-Jakob disease. Neurosci Lett. 344: pp. 132-134 CrossRef
28. Bekris, LM, Lutz, F, Li, G, Galasko, DR, Farlow, MR, Quinn, JF (2012) ADAM10 expression and promoter haplotype in Alzheimer鈥檚 disease. Neurobiol Aging. 33: pp. 2221-2229 CrossRef
29. Li, Y, Liao, F, Yin, XJ, Cui, LL, Ma, GD, Nong, XX (2013) An association study on ADAM10 promoter polymorphisms and atherosclerotic cerebral infarction in a Chinese population. CNS Neurosci Ther. 19: pp. 785-794
30. Kim, M, Suh, J, Romano, D, Truong, MH, Mullin, K, Hooli, B (2009) Potential late-onset Alzheimer鈥檚 disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum Mol Genet. 18: pp. 3987-3996 CrossRef
31. Jian, XQ, Wang, KS, Wu, TJ, Hillhouse, JJ, Mullersman, JE (2011) Association of ADAM10 and CAMK2A polymorphisms with conduct disorder: evidence from family-based studies. J Abnorm Child Psychol. 39: pp. 773-782 CrossRef
32. Levy, MM, Fink, MP, Marshall, JC, Abraham, E, Angus, D, Cook, D (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 29: pp. 530-538 CrossRef
33. Pruessmeyer, J, Hess, FM, Alert, H, Groth, E, Pasqualon, T, Schwarz, N (2014) Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space. Blood. 123: pp. 4077-4088 CrossRef
34. Blume, KE, Soeroes, S, Keppeler, H, Stevanovic, S, Kretschmer, D, Rautenberg, M (2012) Cleavage of annexin A1 by ADAM10 during secondary necrosis generates a monocytic 鈥渇ind-me鈥?signal. J Immunol. 188: pp. 135-145 CrossRef
35. Becker, RE, Berube, BJ, Sampedro, GR, DeDent, AC, Bubeck, WJ (2014) Tissue-specific patterning of host innate immune responses by Staphylococcus aureus alpha-toxin. J Innate Immun. 6: pp. 619-631 CrossRef
36. Isozaki, T, Kasama, T, Takahashi, R, Odai, T, Wakabayashi, K, Kanemitsu, H (2008) Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways. J Inflamm Res. 1: pp. 19-28
37. Hurst, LA, Bunning, RA, Sharrack, B, Woodroofe, MN (2012) siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line. Neurosci Lett 521: pp. 52-56 CrossRef
38. Schwarz, N, Pruessmeyer, J, Hess, FM, Dreymueller, D, Pantaler, E, Koelsch, A (2010) Requirements for leukocyte transmigration via the transmembrane chemokine CX3CL1. Cell Mol Life Sci. 67: pp. 4233-4248 CrossRef
39. Garbers, C, Janner, N, Chalaris, A, Moss, ML, Floss, DM, Meyer, D (2011) Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding. J Biol Chem. 286: pp. 14804-14811 CrossRef
40. Chalaris, A, Rabe, B, Paliga, K, Lange, H, Laskay, T, Fielding, CA (2007) Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood. 110: pp. 1748-1755 CrossRef
41. Mezyk-Kopec, R, Bzowska, M, Stalinska, K, Chelmicki, T, Podkalicki, M, Jucha, J (2009) Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts. Cytokine. 46: pp. 309-315 CrossRef
42. Hiraoka, Y, Yoshida, K, Ohno, M, Matsuoka, T, Kita, T, Nishi, E (2008) Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases. Biochem Biophys Res Commun. 370: pp. 154-158 CrossRef
43. Li, YJ, Fan, YH, Tang, J, Li, JB, Yu, CH (2014) Meprin-beta regulates production of pro-inflammatory factors via a disintegrin and metalloproteinase-10 (ADAM-10) dependent pathway in macrophages. Int Immunopharmacol. 18: pp. 77-84 CrossRef
44. Pabois, A, Devalliere, J, Quillard, T, Coulon, F, Gerard, N, Laboisse, C (2014) The disintegrin and metalloproteinase ADAM10 mediates a canonical Notch-dependent regulation of IL-6 through Dll4 in human endothelial cells. Biochem Pharmacol. 91: pp. 510-521 CrossRef
45. Armstrong, C, Abilleira, S, Sitzer, M, Markus, HS, Bevan, S (2007) Polymorphisms in MMP family and TIMP genes and carotid artery intima-media thickness. Stroke. 38: pp. 2895-2899 CrossRef - 刊物主题：Intensive / Critical Care Medicine; Emergency Medicine;
- 出版者：BioMed Central
- ISSN：1364-8535
文摘
Introduction Although genetic variants of the A disintegrin and metalloproteinase 10 (ADAM10) gene have been shown to be associated with susceptibility to several inflammatory-related diseases, to date little is known about the clinical relationship in the development of sepsis. Methods Two genetic variants in the promoter of ADAM10 were selected to analyze the potential association with the risk of sepsis. A total of 440 sepsis patients and 450 matched healthy individuals in two independent Chinese Han population were enrolled. Pyrosequencing and polymerase chain reaction-length polymorphism was used to determine the genotypes of the rs514049 and rs653765. A real-time qPCR method was used to detect the mRNA level of ADAM10. Enzyme-linked immunosorbent assay was used to measure the expression levels of substrates CX3CL1, interleukin (IL)-6R, tumor necrosis factor alpha (TNF-伪), and the pro-inflammatory cytokines IL-1尾 and IL-6. Luciferase assay was used to analyze the activities of the promoter haplotypes of ADAM10. Results No statistically significant differences between sepsis cases and controls in the genotype or allele frequencies were observed, suggesting that ADAM10 single nucleotide polymorphisms (SNPs) may not be risk factors for the occurrence of sepsis. A significant difference in the genotype and allele frequencies of the rs653765 SNP between patients with sepsis subtype and severe sepsis (P鈥?鈥?.0014) or severe sepsis/sepsis shock (P鈥?鈥?.0037) were observed. Moreover, the rs653765 CC genotype in severe sepsis showed a higher ADAM10 level compared to healthy groups, and the rs653765 CC polymorphism had a strong impact on the production of the ADAM10 substrates CX3CL1, IL-6R and TNF-伪. Furthermore, the functional assay showed that ADAM10 C-A haplotype carriers exhibited significantly higher reporter activity compared with the T-A carriers and T-C carriers in human acute monocytic leukemia cell line. Conclusions Our data initially indicated the ADAM10 rs653765 polymorphism was associated with the development of severe sepsis; the risk CC genotype could functionally affect the expression level of ADAM10 mRNA and was accompanied by the up-regulation of its substrates. Thus, ADAM10 might be clinically important and play a critical role in the pathogenesis of the development of sepsis, with potentially important therapeutic implications.